Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05658874 · ClinicalTrials.gov registry record · Phase 3
A Multidisciplinary, Multimodal Bundled Care Approach to Chronic Pelvic Pain
A Phase 3 study of Interstitial Cystitis, sponsored by Jocelyn Fitzgerald.
- Active
- Registry status
- Phase 3
- Development phase
- 26
- Enrollment target
- 1
- Study location
NCT05658874: Active Phase 3 study of Interstitial Cystitis, sponsored by Jocelyn Fitzgerald.
NCT05658874 is a Phase 3 study of Interstitial Cystitis that is active but no longer recruiting, run by Jocelyn Fitzgerald. The registered enrollment target is 26 participants, below the 361-participant average among 26 other Interstitial Cystitis trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05658874, a Phase 3 study of Interstitial Cystitis, is active but no longer recruiting, sponsored by Jocelyn Fitzgerald.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 3
- Development phase
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to compare two different treatment patterns in patients with chronic bladder pain. The main questions the investigators are seeking to answer is if bladder pain improves before and after treatment using a painful bladder scale. The participant will have 5 visits to evaluate your symptoms with questionnaires, at least one procedural visit, and must participate in physical therapy and some kind of behavioral health therapy. This study will assess participant response to a bundled-care approach to chronic bladder pain both pre-and post intervention as well as compared to a group of participants receiving typical care.
Primary Outcome
This survey assesses IC/BPS symptoms and a change in \> or equal to 4 points is considered clinically significant. A higher score change indicates less pain and urinary symptoms. The minimum possible score is 0. The maximum possible score is 37.
Conditions Studied
Interventions
- DRUG Multimodal Bundle Drugs
- PROCEDURE Operative Cystoscopy
- BEHAVIORAL Behavioral health consultation/therapy
- OTHER Pelvic floor physical therapy
- OTHER Usual Urogynecologic care
Study Locations (1)
Pennsylvania
- Magee Womens Hospital - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2022-12-01 |
| Est. Completion | 2025-10-31 |
| Phase | Phase 3 |
What the registry record for NCT05658874 still lists
NCT05658874 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 361-participant average among 26 other Interstitial Cystitis trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Interstitial Cystitis appearing as the primary indexed condition, and to 5 interventions - of which Multimodal Bundle Drugs is the first listed.
NCT05658874 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05658874 about?
NCT05658874 is a clinical study titled "A Multidisciplinary, Multimodal Bundled Care Approach to Chronic Pelvic Pain". The goal of this clinical trial is to compare two different treatment patterns in patients with chronic bladder pain. The main questions the investigators are seeking to answer is if bladder pain improves before and after treatment using a painful bladder scale. The participant will have 5 visits to...
What is the current status of trial NCT05658874?
This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 26 participants. The study started on 2022-12-01. Estimated completion is 2025-10-31.
What conditions does trial NCT05658874 study?
This clinical trial studies the following conditions: Interstitial Cystitis.
What interventions are being tested in trial NCT05658874?
The interventions under investigation include: Multimodal Bundle Drugs (DRUG), Operative Cystoscopy (PROCEDURE), Behavioral health consultation/therapy (BEHAVIORAL), Pelvic floor physical therapy (OTHER), Usual Urogynecologic care (OTHER).
Who is sponsoring clinical trial NCT05658874?
This trial is sponsored by Jocelyn Fitzgerald, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05658874 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Interstitial Cystitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05658874's enrollment target sits among peer trials
26 21st of 26 higher than 6 of 26 other Interstitial Cystitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Interstitial Cystitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of Amitriptyline for Painful Bladder Syndrome (PBS)
COMPLETED · Phase 3
-
Clinical Trial Comparing Two Bladder Instillations for IC/BPS
COMPLETED · Phase 3
-
Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment
RECRUITING · NA
-
Peppermint Oil for the Treatment of Interstitial Cystitis / Bladder Pain Syndrome
RECRUITING · Phase 1
-
Motor Cortical Neuromodulation in Women With Interstitial Cystitis/Bladder Pain Syndrome
RECRUITING · NA
-
Identifying Genetic Causes of IC/BPS
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI